| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/04/2001 | CN1301541A Health care product containing lactein and its preparing method |
| 07/04/2001 | CN1068000C Apolioprotein -B synthesis inhibitors |
| 07/04/2001 | CN1067992C Substituted thiazolidine derivatives and pharmaceutical compounds containing them and use thereof |
| 07/04/2001 | CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/03/2001 | US6255471 CRFG-1b, a target and marker for chronic renal failure |
| 07/03/2001 | US6255468 MPROT12 polynucleotides and methods thereof |
| 07/03/2001 | US6255351 Treatment of bone disorders |
| 07/03/2001 | US6255341 Nutrients; mixture of vitamins, triglycerides and protein |
| 07/03/2001 | US6255338 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors |
| 07/03/2001 | US6255306 4-indole derivatives as serotonin agonists and antagonists |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6255096 An isolated nucleic acid encoding an amino acid; diagnosis and therapy for progressive mental retardation in conjuction with skeletal deformities |
| 07/03/2001 | US6254904 Comprising: (6s)-tetrahydrofolic acid and derivatives and polyglutamyl derivatives; multivitamin breakfast foods, infant formulas, dietary supplements and animal feed preparation |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2012115C Iodinated somatostatins |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/29/2001 | CA2329576A1 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-ht1d receptor selective antagonists |
| 06/28/2001 | WO2001046413A1 Novel gene and use thereof |
| 06/28/2001 | WO2001046397A2 Human kinases |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046355A1 Stabilisation of pigments and polyunsaturated oils and oil concentrates |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046206A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046205A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046204A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | WO2001046203A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046196A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | WO2001046176A2 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | WO2001046146A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046145A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046144A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046131A1 Method for making 24(s)-hydroxyvitamin d¿2? |
| 06/28/2001 | WO2001045752A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | WO2001045749A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | WO2001045723A1 Medicines manufactured from old platycodon extracts |
| 06/28/2001 | WO2001045714A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045711A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045700A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045695A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 06/28/2001 | WO2001045694A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045689A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2001 | WO2001045679A2 Use of chemotherapeutic agents for topical treatment |
| 06/28/2001 | WO2001045664A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 06/28/2001 | WO2001045663A2 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045484A2 An improved process for preparing simvastatin |
| 06/28/2001 | WO2001009122A3 Serotonergic benzofurans |
| 06/28/2001 | WO2001005974A9 The il-1l1 gene and polypeptide products |
| 06/28/2001 | WO2000077186A3 Bacterial protection against stress |
| 06/28/2001 | WO2000077010A3 Substituted heterocycle fused gamma-carbolines |
| 06/28/2001 | WO2000074710A3 Methods for treating diabetes |
| 06/28/2001 | WO2000073331A3 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO2000057865A3 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 06/28/2001 | WO2000040569A8 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | US20010005719 Compositions and methods for treatment of mitochondrial diseases |
| 06/28/2001 | US20010005714 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 06/28/2001 | US20010005514 L-ascorbic acid and pectin composition |
| 06/28/2001 | DE19962936A1 New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis |
| 06/28/2001 | DE19960204A1 Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Norlbornylamino substituted derivatives, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | CA2717246A1 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
| 06/28/2001 | CA2438477A1 An improved process for preparing simvastatin |
| 06/28/2001 | CA2399584A1 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | CA2395520A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | CA2395466A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | CA2395435A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395102A1 Human kinases |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394834A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2394757A1 Novel gene and use thereof |
| 06/28/2001 | CA2394624A1 Method for making 24(s)-hydroxyvitamin d2 |
| 06/28/2001 | CA2394603A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393367A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393363A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393359A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2363837A1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1110959A1 Process for selective lactonization |
| 06/27/2001 | EP1110550A2 Composition comprising ascorbic acid and pectin |
| 06/27/2001 | EP1110548A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof |
| 06/27/2001 | EP1109909A2 Grf analogs with increased biological potency |
| 06/27/2001 | EP1109908A2 Leptin induced genes |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |